Generate a tailored SOP for Dr. Pankti Reid. Improve your application with a focused, well-structured draft.
Dr. Pankti Reid is an Associate Professor in the Biological Sciences Division at the University of Chicago. With a specialization in clinical pharmacology and pharmacogenomics, her research focuses on immune-related adverse events associated with cancer treatments. She contributes significant insights into comparative safety profiles of biologic targeted synthetic therapies and their implications for cardiovascular outcomes in rheumatoid arthritis. Her ongoing work explores the impact of steroid-sparing immunosuppressive agents in the context of cancer immunotherapy, particularly in melanoma and non-small-cell lung cancer. Dr. Reid is also actively involved in clinical practice, emphasizing the management of immunotherapy-related toxicities and the development of clinical infrastructure for the evaluation of immune-related adverse events. She has published extensively, including articles in renowned medical journals such as JAMA Network Open and Frontiers in Immunology. Dr. Reid’s commitment to improving therapeutic strategies for cancer patients positions her as a leading researcher in the intersection of pharmacology and oncology.
Department of Philosophy